Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Taxotere docetaxel: Phase III data

In the European, open-label Phase III TAX 323 trial, induction treatment with Taxotere

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE